Glactone Pharma Development AB
Records under this name other than the patents Glactone Pharma Development AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 4 of 4 · Back to Glactone Pharma Development AB
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,538,500 | Tricyclic prodrugs Lapsed on the fee record Ended Jan 21, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jan 21, 2024 | From the USPTO record |
| US 9,150,531 | Tricyclic lactones for treatment of cancer Lapsed on the fee record Ended Oct 6, 2023 · From the USPTO record | Lapsed on the fee record | Ended Oct 6, 2023 | From the USPTO record |
| US 10,351,577 | Ether analogues of galiellalactone Lapsed on the fee record Ended Jul 16, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jul 16, 2023 | From the USPTO record |
| US 10,077,246 | Tricyclic prodrugs Lapsed on the fee record Ended Sep 18, 2022 · From the USPTO record | Lapsed on the fee record | Ended Sep 18, 2022 | From the USPTO record |